Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

LeukoSite, Warner-Lambert and Kyowa Hakko chemokine drug discovery collaboration

Nov. 13, 1997

ICAgen receive SBIR grant for ion channel drug target research

Nov. 11, 1997

Proof of principle demonstrated for Titan's drug delivery system

Nov. 11, 1997

Myriad creates CNS database for potential drug discovery

Nov. 7, 1997

U.S. patent issued for Cambridge NeuroScience's drug delivery system

Nov. 6, 1997

Genetronics cleared to proceed with electroporation trial in France

Nov. 6, 1997

CellPro: Q2 1997 highlights

Nov. 6, 1997

Karo Bio/Merck & Co. form strategic alliance related to ER receptors

Nov. 5, 1997

FibroGen granted license to Zeneca antifibrotic compounds

Nov. 3, 1997

Genzyme General and Acadia enter drug discovery collaboration

Nov. 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.